Test Research Inc
TWSE:3030
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
61.3
189.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Test Research Inc
Total Liabilities & Equity
Test Research Inc
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Test Research Inc
TWSE:3030
|
Total Liabilities & Equity
NT$10.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
FIT Holding Co Ltd
TWSE:3712
|
Total Liabilities & Equity
NT$54.5B
|
CAGR 3-Years
50%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
P
|
Posiflex Technology Inc
TWSE:8114
|
Total Liabilities & Equity
NT$16.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
20%
|
|
|
Hiwin Mikrosystem Corp
TWSE:4576
|
Total Liabilities & Equity
NT$6.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Flytech Technology Co Ltd
TWSE:6206
|
Total Liabilities & Equity
NT$6.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Chroma ATE Inc
TWSE:2360
|
Total Liabilities & Equity
NT$36B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
Test Research Inc
Glance View
Test Research, Inc. engages in the manufacture and sale of assembled circuit board automatic test equipment. The company is headquartered in Taipei City, Taipei. The company went IPO on 2001-03-21. The firm mainly operates through two business segments. The Circuit Boards Testing Equipment segment is mainly engaged in the manufacturing of circuit board testing equipment. The Semiconductors Testing Equipment segment is engaged in the manufacturing of testing equipment for chips and end products. The firm is also engaged in the provision of labor services. The firm mainly distributes its products in domestic market and overseas markets, including the People’s Republic of China (the PRC), the United States of America (the USA) and other countries and regions.
See Also
What is Test Research Inc's Total Liabilities & Equity?
Total Liabilities & Equity
10.5B
TWD
Based on the financial report for Jun 30, 2024, Test Research Inc's Total Liabilities & Equity amounts to 10.5B TWD.
What is Test Research Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
5%
Over the last year, the Total Liabilities & Equity growth was 15%. The average annual Total Liabilities & Equity growth rates for Test Research Inc have been 8% over the past three years , 8% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
